Chapter 3

Hypertrophic Cardiomyopathy in Pediatric Population

Sarah Moharem Elgamal, Shehab M. Anwer and El Tahlawi Mohammad

Abstract

Hypertrophic cardiomyopathy (HCM) is an inherited autosomal dominant genetic disease characterised by asymmetrical increased wall thickness of a non-dilated LV chamber. It has a diverse natural history which is attributed to its heterogeneous clinical presentation. HCM could be diagnosed clinically, by ECG changes and definitely by echocardiographic characteristics. Pharmacological therapy has an important role in the management of HCM. Alcohol septal ablation and pacing may be used in certain conditions. Septal myectomy, Morrow procedure, is indicated to reduce persistent gradient and alleviate symptoms refractory to medications.

Total Pages: 59-83 (25)

Purchase Chapter  Book Details

RELATED BOOKS

.Nanomedicinal Approaches Towards Cardiovascular Disease.
.Pharmacotherapeutic Management of Cardiovascular Disease Complications: A Textbook for Medical Students.
.Perinatal Cardiology-Part 1.
.Perinatal Cardiology-Part 2.
.Otolaryngology for the Pediatrician.
.Synopsis of General Pediatric Practice.